You are viewing a single comment's thread.

view the rest of the comments →

letsdothis2 ago

David Geffen School of Medicine and Haiti: https://www.voat.co/v/pizzagate/2414228/12012594

They are involved with stem cell research too:

http://californiastemcellreport.blogspot.com/2009/02/financially-troubled-cirm-hires-200000.html

The California stem cell agency has hired one of Washington's more influential lobbyists, The Podesta Group, to promote a $10 billion biomedical industry aid package being pushed by CIRM Chairman Robert Klein.

In response to an inquiry, Don Gibbons, CIRM communications chief, today said a contract had been signed with the firm, which was founded by Tony Podesta (see photo) in 1988

In addition to grabbing some cash right now, Podesta said, "Our strategy also positions CIRM to play a major role in shaping longer-term federal policies on biomedical research in general and stem cells in particular."

The firm said it is "the longest-tenured Washington representative of the pioneer biotech companies – Genzyme, Genentech and Amgen." It also represents Novartis Vaccines and Diagnostics and Novo Nordisk. Business Week has labelled The Podesta Group as one of seven "Uber-influencers: The Lobbyists Likely to thrive in the New Washington."

The hiring of the lobbyist has drawn fire from at least one critic, John M. Simpson, stem cell project director of Consumer Watchdog of Santa Monica, Ca., who has called it an unnecessary, costly diversion from CIRM's stem cell research mission in California.

https://stemcell.ucla.edu/news/new-grant-funds-cutting-edge-ucla-clinical-trial-late-stage-lung-cancer

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have been awarded a $12M grant from the California Institute for Regenerative Medicine – also known as CIRM – to initiate a phase 1 clinical trial to test a novel cancer treatment for advanced-stage lung cancer.

“New immunotherapy drugs such as pembrolizumab are effective for approximately 20 percent of lung cancer patients, so new options are needed for combination therapies that improve these results,” said Dubinett, a professor of medicine, chief of the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine and a member of the UCLA Broad Stem Cell Research Center.

Highly relevant comments in this link: Trump tweets about Tony Podesta. Maybe because of his connections with biotech companies like Genentech, the Bertarelli Foundation and their links with the Swiss Guard of the Vatican.

and:

Don't forget the Geffen Playhouse https://voat.co/v/pizzagate/2063874/10201987

https://voat.co/v/pizzagate/2202687/10843417

which leads to the Wasserman Foundation and Casey Wasserman > Jules Stein Eye Institute > UCLA David Geffen School of Medicine

Shizy ago

Excellent finds! Thank you so much! Weaseling his way into the UCLA med school didn't sit well with me because of these people's fascination with adrenochrome and life extension. I had no idea about the Haiti connection, but that makes total sense.